APA (7th ed.) Citation

X, H., Y, X., ES, V., H, Z., IR, L., J, S., . . . BG, D. (2026). Soluble E-cadherin-CXCL1-CXCR2 axis as a therapeutic vulnerability in inflammatory breast cancer brain metastasis. Neuro-oncology, 28(5), 1220. https://doi.org/10.1093/neuonc/noag012

Chicago Style (17th ed.) Citation

X, Hu, et al. "Soluble E-cadherin-CXCL1-CXCR2 Axis as a Therapeutic Vulnerability in Inflammatory Breast Cancer Brain Metastasis." Neuro-oncology 28, no. 5 (2026): 1220. https://doi.org/10.1093/neuonc/noag012.

MLA (9th ed.) Citation

X, Hu, et al. "Soluble E-cadherin-CXCL1-CXCR2 Axis as a Therapeutic Vulnerability in Inflammatory Breast Cancer Brain Metastasis." Neuro-oncology, vol. 28, no. 5, 2026, p. 1220, https://doi.org/10.1093/neuonc/noag012.